IMS Sample Clauses

IMS the sole proprietary company Instant Management Systems, or any legal successor thereof.
AutoNDA by SimpleDocs
IMS. On February 20, 1996, RTC acquired IMS. The four dialysis facilities acquired are located in Hawaii and serviced a total of approximately 444 patients as of the acquisition date. The transaction was accounted for under the pooling-of- interests method of accounting. In the transaction, RTC issued 1,047,464 shares of its common stock in exchange for all of the outstanding stock of IMS. The consolidated financial statements give retroactive effect to the mergers with the Kidney Center Group, IMS and MDU and include the Kidney Center Group, IMS and MDU for all periods presented. The following is a summary of the separate and combined results of operations for 1996: Pooling RTC Companies* RTC Combined Net patient revenue................ $217,529,000 $7,548,000 $225,077,000 Income from operations............. 20,495,000 1,180,000 21,675,000 Net income......................... 9,985,000 697,000 10,682,000 - -------- * Includes pooling transactions only for period prior to acquisition. Activity subsequent to acquisition dates is included in RTC. Acquisitions We have implemented an acquisition strategy which, through December 31, 1998, has resulted in the acquisition of (a) 396 facilities providing services to ESRD patients; (b) two laboratories; (c) a pharmacy; (d) a vascular access management company; and (e) a clinical research company specializing in renal and renal-related services. The following is a summary of acquisitions that were accounted for as purchases for 1996, 1997 and 1998. Year ended December 31, -------------------------------------- 1996 1997 1998 Number of facilities acquired.......... 67 119 76 Number of common shares issued......... 102,645 17,613 98,549 Estimated fair value of common shares issued................................ $ 1,830,000 $ 273,000 $ 2,796,000 Acquisition obligations (Note 8)....... 15,886,000 15,233,000 Cash paid, net of cash acquired........ 179,002,000 455,090,000 338,164,000 ------------ ------------ ------------ Aggregate purchase price............... $196,718,000 $455,363,000 $356,193,000 ============ ============ ============ In addition, during this period we developed 52 de novo facilities, three of which we manage, entered into management contracts covering an additional 29 unaffiliated facilities, and purchased the minority interest at nine of our existing facilities. TOTAL RENAL CARE HOLDINGS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(Continued) The assets and liabilities of the acquired entities in th...
IMS. USL will allow LES to use its proprietary IMS software and database for a period of 6 months after the Closing Date, royalty-free. Additionally, LES will only be allowed to use IMS as part of the normal conduct of the Acquired Business Operations. Any sale, assignment, transfer, conveyance or unlawful use of this IMS software will result in termination of this Agreement.
IMS. IMS is a USL developed application, thus, USL will provide full service and support for this application and database for the duration indicated above. This will include general support, work stoppage bug modifications, database support, report support, and overall functional support. This does not include major code revisions nor modifications of the existing IMS system as determined by USL’s IT staff and Arya Fxxxxxxxx.
IMS. Net(TM) Software. The "IMS-Net(TM) Software" is a series of -------------------- independent but interrelated computer programs, which includes the PC-Com(TM) Software, the Com-Center(TM) Software and Network Interface, which interacts with a central processor and remotely located personal computers and their operating systems to form a complete and functioning network by which medical and other information and data, text, voice, clinical graphics and diagnostic images can be transmitted, shared, stored and accessed randomly over a dial-up telephone network. The IMS-Net(TM) Software includes, but is not limited to, computer program listings, user manuals, functional specifications, technical documentation, source code, object code, related procedure codes and tangible media upon which the computer programs are recorded. The IMS-Net(TM) Software performs the functions described on Exhibit A attached to the Software License Agreement and shall be licensed to the Company pursuant to the covenants, terms and conditions of the Software License Agreement.
IMS. The term
IMS. In the event IMS is unable or unwilling, on terms (including, without limitation, quality standards) acceptable to WL, to provide data to WL which will enable WL to make the calculations required pursuant to SECTION 6.1, WL will notify Ascent of such fact and WL will, after consultation with Ascent, select a new third party supplier of such data.
AutoNDA by SimpleDocs
IMS. The IMS MATECS-MTP initiative (Deliverable D6.5) was published in due time on the Intelligent Manufacturing System (IMS) website in quest for extended partnership and was promoted at the IMS meeting that was held in Lugano, CH, by end of June 2010. Thanks to specific promotion performed during subsequent ISO TC39/SC2 meetings, we convinced the Korean delegates to pursue the steps needed to ensure the active participation of Korea, thus reaching the minimum threshold of three IMS regions. The Memorandum of Understanding (MOA) was signed in May 2012.

Related to IMS

  • Cornerstone shall notify the LLC and confirm such advice in writing (i) when the filing of any post-effective amendment to the Registration Statement or supplement to the Prospectus is required, when the same is filed and, in the case of the Registration Statement and any post-effective amendment, when the same becomes effective, (ii) of any request by the Securities and Exchange Commission for any amendment of or supplement to the Registration Statement or the Prospectus or for additional information and (iii) of the entry of any stop order suspending the effectiveness of the Registration Statement or the initiation or threatening of any proceedings for that purpose, and, if such stop order shall be entered, Cornerstone shall use its best efforts promptly to obtain the lifting thereof.

  • Baxter and Nexell shall cooperate in any action taken by a third party solely involving a nullity action, opposition, reexamination or any other action taken by such third party alleging the invalidity or unenforceability of any Licensed Intellectual Property. Both parties agree to share equally in the cost of the defense of such Licensed Intellectual Property.

  • Medi Cal PII is information directly obtained in the course of performing an administrative function on behalf of Medi-Cal, such as determining Medi-Cal eligibility or conducting IHSS operations, that can be used alone, or in conjunction with any other information, to identify a specific individual. PII includes any information that can be used to search for or identify individuals, or can be used to access their files, such as name, social security number, date of birth, driver’s license number or identification number. PII may be electronic or paper. AGREEMENTS

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Information Technology The following applies to all contracts for information technology commodities and contractual services. “Information technology” is defined in section 287.012(15), F.S., to have the same meaning as provided in section 282.0041, F.S.

  • Clinical Data The descriptions of the results of any studies and tests conducted by or on behalf of, or sponsored by, the Company or its subsidiaries, or in which the Company has participated, that are described in the Disclosure Package and the Prospectus, or the results of which are referred to in the Disclosure Package and the Prospectus do not contain any misstatement of material fact or omit to state a material fact necessary to make such statements not misleading. The Company has no knowledge of any studies or tests not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Disclosure Package or Prospectus.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Motorola s sole obligation to Licensee and Licensee’s exclusive remedy under this warranty is to use reasonable efforts to remedy any material Software defect covered by this warranty. These efforts will involve either replacing the media or attempting to correct significant, demonstrable program or documentation errors or Security Vulnerabilities. If Motorola cannot correct the defect within a reasonable time, then at Motorola’s option, Motorola will replace the defective Software with functionally-equivalent Software, license to Licensee substitute Software which will accomplish the same objective, or terminate the license and refund the Licensee’s paid license fee.

  • Information Services The Custodian may rely upon information received from issuers of Securities or agents of such issuers, information received from Subcustodians or depositories, information from data reporting services that provide detail on corporate actions and other securities information, and other commercially reasonable industry sources; and, provided the Custodian has acted in accordance with the standard of care set forth in Section 6 (a), the Custodian shall have no liability as a result of relying upon such information sources, including but not limited to errors in any such information.

Time is Money Join Law Insider Premium to draft better contracts faster.